Study #2021-1019
Dosimetry and bio-distribution of 68Ga-RMX-VH in newly diagnosed or recurrent patients with solid tumors: A Phase I exploratory study
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Phase I 68Ga-RMX-VH in newly diagnosed or recurrent solid tumors
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Phase I
Physician name:
Vinaykumar Puduvalli
Department:
Neuro-Oncology
For general questions about clinical trials:
1-866-419-2881
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.